Editor of Patient Care Online.
The Daily Dose from Patient Care Online: October 11, 2022
Your daily dose of clinical news from Patient Care Online.
Ustekinumab Demonstrates Sustained Clinical, Corticosteroid-free Remission at 4 Years in Adults with Moderate-to-Severe Ulcerative Colitis
Over half of induction responder patients who received ustekinumab at maintenance baseline were in symptomatic remission 4 years later, according to data presented at UEG Week 2022.
Remdesivir for Treatment of Severe COVID-19: Expert Reviews Latest Evidence
Elizabeth Sapey, PhD, discusses findings from the SOLIDARITY study and similar research on the efficacy of remdesivir for treatment of severe disease.
4 New Drugs Approved for Primary Care: Q3 2022
Novel NMDA receptor antagonist approved for the treatment of major depressive disorder, first topical PDE4i approved for plaque psoriasis, and more.
FDA Grants Fast Track Designation to Tirzepatide for Treatment of Obesity, Overweight in Adults
The first-in-class dual incretin receptor agonist was granted fast track designation for investigation in adults with obesity or overweight with weight-related comorbidities.
Candy, Pastries a Gateway to Higher Unhealthy Food Intake among Adolescents, New Study Finds
Findings show that increased consumption of candy among adolescents was linked to a 31% increase in intake of all other ultraprocessed foods.
Food Insecurity Rose among US Adults with Cardiovascular Disease, According to National Study
The rate of food insecurity among persons with CVD nearly doubled over 20 years, according to new research.
WHO Recommends Remdesivir for Severe COVID-19: Expert Perspective on Updated Therapeutic Guideline
Elizabeth Sapey, PhD, discusses the updated recommendations and the research that prompted the decision.
Mobile Health Technology for Pain Management
A discussion with Lynn Webster, MD, about the importance and future of mobile health technology for chronic pain management.
Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Lynn Webster, MD, past president of the American Academy of Pain Medicine.
Primary Care Clinician-focused EHR Program Found Effective in Helping Children Achieve Healthy Weight
Children with obesity enrolled in the FitTastic study group had more favorable BMI patterns compared to control group, according to longitudinal effectiveness study.
Mental Health Treatment Utilization in America: 5 Findings from National Center for Health Statistics Report
The percentage of adults who received any mental health treatment increased, women were more likely than men to receive treatment, and 3 more key findings.
Former Smokers who Adhere to Healthy Lifestyle Lower Their Risk of Early Death, Large Analysis Finds
An analysis of over 159 000 former smokers found that those who adhered to lifestyle recommendations lowered their risk of premature death by over 25%.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 23, 2022
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Adolescents with Severe Obesity Lost Weight and Sustained it After Bariatric Surgery, New Research Finds
Adolescents with severe obesity who underwent bariatric surgery before age 22 lost 31.1% body weight and kept it off over a decade later, showed new study.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 21, 2022
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 20, 2022
Phase 3 Trial Now Underway of Investigational mRNA-based Influenza Vaccine
Pfizer announced that the first participants have been dosed in a novel phase 3 efficacy clinical trial of its quadrivalent modified RNA influenza vaccine candidate.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 19, 2022
Study: At-home COVID-19 Tests Less Effective After Omicron Emergence
The performance of 3 commercially available COVID-19 home-testing kits worsened during the emergence of the omicron variant, according to a new cross-sectional study.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 16, 2022
Percentage of Americans Receiving Mental Health Treatment Rose during Pandemic, New NCHS Data Brief Shows
New research shows that the percentage of adults who had received any mental health treatment in the past year increased by nearly 5% from 2019 to 2021.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 15, 2022
Arthritis in Older Adults: Patient Thoughts on Symptoms, Management, & Clinician Counseling
New findings from a national survey shed light on patient attitudes and experiences with arthritis and joint pain.
Urban Areas in US are Associated with Lower Rates of Hypertension Medication Adherence, New Study Finds
AHA Hypertension 2022: New research showed that hypertension medication adherence was nearly 76% in large urban areas and increased as population density decreased.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 13, 2022
Two-thirds of Older Adults with Arthritis Use OTC Treatments, yet Many Do not Consult with Clinician about Medication Risks
Findings from the University of Michigan National Poll on Healthy Aging highlight the need for clinicians to raise the topic of joint pain with their older patients.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 12, 2022
Abelacimab Receives Fast Track Designation from FDA for Prevention of Stroke, Systemic Embolism in Patients with Atrial Fibrillation
Abelacimab is a dual-acting, fully human monoclonal antibody that selectively targets both factor XI and factor XIa with high affinity.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 9, 2022
